Copyright
©The Author(s) 2022.
World J Diabetes. Jul 15, 2022; 13(7): 532-542
Published online Jul 15, 2022. doi: 10.4239/wjd.v13.i7.532
Published online Jul 15, 2022. doi: 10.4239/wjd.v13.i7.532
Table 3 Comparison of estimated values of macular retinal thickness, macular choroidal thickness, foveal no perfusion area between the two groups (mean ± SD)
| Groups | Before treatment | 1 mo after treatment | 3 mo after treatment |
| CMT (μm) | |||
| Compaq group (n = 48) | 445.8 ± 89.6 | 372.1 ± 76.0 | 210.6 ± 66.4 |
| Ranibizumab group (n = 48) | 452.7 ± 93.2 | 384.0 ± 80.6 | 243.1 ± 73.5 |
| t value | -0.370 | -0.744 | -2.273 |
| P value | 0.712 | 0.459 | 0.025 |
| SFCT (μm) | |||
| Compaq group (n = 48) | 335.1 ± 55.9 | 323.4 ± 59.5 | 281.6 ± 54.0 |
| Ranibizumab group (n = 48) | 340.5 ± 58.3 | 330.5 ± 63.0 | 306.2 ± 57.3 |
| t value | -0.463 | -0.568 | -2.165 |
| P value | 0.644 | 0.572 | 0.033 |
| FAZ (mm2) | |||
| Compaq group (n = 48) | 0.74 ± 0.10 | 0.72 ± 0.12 | 0.73 ± 0.11 |
| Ranibizumab group (n = 48) | 0.75 ± 0.12 | 0.74 ± 0.14 | 0.74 ± 0.11 |
| t value | -0.444 | -0.751 | -0.445 |
| P value | 0.658 | 0.454 | 0.657 |
- Citation: Li YF, Ren Q, Sun CH, Li L, Lian HD, Sun RX, Su X, Yu H. Efficacy and mechanism of anti-vascular endothelial growth factor drugs for diabetic macular edema patients. World J Diabetes 2022; 13(7): 532-542
- URL: https://www.wjgnet.com/1948-9358/full/v13/i7/532.htm
- DOI: https://dx.doi.org/10.4239/wjd.v13.i7.532